Sign in

    Charles

    Research Analyst at Mizuho Securities USA LLC

    Charles is an analyst at Mizuho Securities USA LLC with a focus on equity research in the financial sector, covering notable companies such as Global Payments and SM Energy. He is recognized for delivering insightful analysis and recommendations that have contributed to solid investment performance, with tracked calls on major mid-cap stocks. Charles began his career in the early 2010s, gaining experience at reputable financial institutions before joining Mizuho Securities. He holds key professional credentials, including FINRA registration and relevant securities licenses, underscoring his commitment to industry standards and regulatory compliance.

    Charles's questions to ARMSTRONG WORLD INDUSTRIES (AWI) leadership

    Charles's questions to ARMSTRONG WORLD INDUSTRIES (AWI) leadership • Q1 2025

    Question

    Charles asked for the rationale behind the cautious second-half outlook despite strong current orders, questioning if it was conservatism or signs of a slowdown. He also inquired about Mineral Fiber mix trends, the risk of trade-downs, and historical mix performance during downturns.

    Answer

    CEO Victor Grizzle explained that the second-half forecast is based on historical precedent where market uncertainty, such as that caused by tariffs, leads to a pause in discretionary renovation projects. He noted this is an experiential forecast, as current on-the-ground bidding activity remains steady. Grizzle also stated that the company is not seeing any signs of product trade-down; in fact, Q1 saw a positive mix, a trend that has persisted even through prior downturns, supported by innovation in higher-AUV products like TEMPLOK.

    Ask Fintool Equity Research AI

    Charles's questions to Evolus (EOLS) leadership

    Charles's questions to Evolus (EOLS) leadership • Q4 2024

    Question

    Charles, on for Uy Ear, asked about expectations for service revenues in 2025, the reason for negative service revenue in Q4 2024, and whether the projected growth for international Nuceiva sales is proportional or simply year-over-year.

    Answer

    CFO Sandra Beaver explained that service revenue is a stable, non-material stream from a single contract in Canada and is subject to timing variations. Regarding international Nuceiva sales, she confirmed they are expected to grow meaningfully faster than the U.S. business from a smaller base. She noted that international revenue was approximately 5% of total revenue in 2024 and expects that percentage to continue increasing.

    Ask Fintool Equity Research AI

    Charles's questions to BW LPG (BWLP) leadership

    Charles's questions to BW LPG (BWLP) leadership • Q4 2024

    Question

    An analyst identified as Charles asked about the strategy behind using share issuance for financing, the rationale for paying dividends in excess of shipping earnings, and the perceived reasons for the shipping industry's persistently low price-to-earnings multiples.

    Answer

    CEO Kristian Sørensen explained that the share issuance for the Avance Gas transaction was accretive, as it was done when the share price was near NAV. He clarified that the dividend was not in excess of total earnings, as it included a special payout from the profitable Product Services segment. He attributed low P/E multiples to earnings volatility, which BW LPG mitigates through time charters and diversification, and noted that current geopolitical risks also weigh on industry perception.

    Ask Fintool Equity Research AI

    Charles's questions to RELMADA THERAPEUTICS (RLMD) leadership

    Charles's questions to RELMADA THERAPEUTICS (RLMD) leadership • Q3 2024

    Question

    Charles from Mizuho asked for clarification on the patient enrollment target for the Reliance II study if the DMC recommends continuing without changes.

    Answer

    CEO Sergio Traversa responded that the planned number of patients is between 300 and 340. He noted that in such a scenario, the company would likely enroll a few percent more than the planned number to account for potential dropouts.

    Ask Fintool Equity Research AI